Pipeline
Surrozen submits IND to FDA for DME therapeutic
Phase 1b/2a study to evaluate a bifunctional Wnt agonist and VEGF antagonist antibody that targets vascular leakage and promote retinal vascular integrity
Business
GMAC names 2026-2027 international advisory panel
Global Myopia Awareness Coalition appoints seven experts to support ongoing mission in raising global awareness of childhood myopia.
Business
AMA supports formal classification of myopia as a disease
Adopted resolution calls for comprehensive insurance coverage and reimbursement for evidence-based treatments demonstrated to slow myopia progression.
Pipeline
FDA grants IDE approval to Ciliatech for glaucoma implant study
Clearance brings company closer to a clinical and regulatory pathway for the cilioscleral interpositioning device, designed to lower IOP in POAG.
Pipeline
FDA accepts Nanoscope's optogenetic gene therapy BLA for RP
The newly-renamed MOGENRY could become the first gene-agnostic treatment for patients with RP having severe vision loss.
Research
Deep learning ties retinal features to Alzheimer's risk factors
Researchers used AI to analyze retinal photographs and uncover patterns associated with disease risk factors years before dementia developed.
Pipeline
Ocugen doses first patient in phase 3 GA gene therapy trial
OCU410 becomes third gene therapy from Ocugen to reach late-stage clinical trials; BLA filing is anticipated in 2028.
Business
Leadership watch: Samsara, Claris Bio, Staar Surgical, Wills Eye, and more
Leadership changes are underway in the eyecare space—and we’ve got the latest.
Research
Study: Earlier RD surgery predicts stronger visual outcomes
Patients with faster repair and better baseline vision achieved stronger 6-month recovery, regardless of detachment anatomy.
Products
Alcon introduces UNITY M ophthalmic microscope
Latest addition to the UNITY platform offers improved ergonomics and advanced visualization technologies; commercial rollout set for later this year.
Events
Bausch + Lomb debuts IOL Compass framework for premium lens decisions
One-day-only, faculty-led surgeon education program routes candidacy, lens match, and post-op care into one system.
Products
Sightview launches EHR, PM platform for ophthalmologists
Eyecare-only software developer unveils modernized electronic health record and practice management solution with enhanced end-to-end functionality.
Events
Registration opens for Eyes on Retina 2026
EOE’s virtual event of the year for retina-focused ECPs kicks off in October—with the chance to claim up to 5 hours of CE or CME.
Legal
Illinois passes new OD protections against VBMs
Expansion of the state’s 2023 Vision Care Plan Regulation Act, SB 3070 enacts new protections for ECPs and patients—plus greater vision benefit flexibility.
Pipeline
Oculis doses first patient in phase 3 privosegtor trial for ON
PIONEER-1 pivotal trial is evaluating the neuroprotective therapeutic among ON patients with and without multiple sclerosis.
Products
X-Cel Specialty Contacts launches new overnight ortho-k lens
With Essilor Custom Contacts, Lunara is manufactured with an FDA PMA-approved lens material; features flexible optic zone and diameter options.
Research
Maternal asthma may increase ROP risk
A new study found that preterm infants born to mothers with asthma had higher odds of developing treatment-warranted retinopathy of prematurity.
Pipeline
FDA accepts Nicox's NDA for IOP-lowering glaucoma drop
PDUFA target action date of April 30, 2027, is set for the newly-renamed K-911, a nitric oxide-donating bimatoprost formulation.
Research
Does obesity increase risk for pediatric astigmatism?
Obese children were twice as likely to have clinically meaningful astigmatism, with the suspected culprit being eyelid pressure on the cornea.
Products